J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 77 (1996), 753-758; DOI 10.1099/0022-1317-77-4-753
© 1996 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schønning, K.
Right arrow Articles by Hansen, J.-E. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schønning, K.
Right arrow Articles by Hansen, J.-E. S.
Agricola
Right arrow Articles by Schønning, K.
Right arrow Articles by Hansen, J.-E. S.

Rapid selection for an N-linked oligosaccharide by monoclonal antibodies directed against the V3 loop of human immunodeficiency virus type 1

Kristian Schønning1, Britt Jansson2, Sigvard Olofsson2 and John-Erik Stig Hansen1,*

1 Laboratory for Infectious Diseases, Department 144, Hvidovre Hospital, Kettegård Allé 30, 2650 Hvidovre, Denmark
and2 Department of Clinical Virology, University of Göteborg, 413 46, Sweden

The V3 loop of the human immunodeficiency virus (HIV) surface protein, gp120, constitutes a principal neutralizing determinant. HIV strains lacking a naturally conserved N-linked oligosaccharide (at position 306) within the V3 loop are highly sensitive to neutralization. We subjected molecular clones of HIVLAI lacking this 306N-glycan to in vitro immune selection with MAbs directed against the V3 loop. In all, ten clones were characterized, and all proved resistant to V3-directed neutralization. Sequencing of the V3 loop revealed that six of the clones had become resistant at least partly by reacquisition of the 306N-glycan. Only two of the clones possessed mutations within the binding site of the antibody itself, while the two remaining clones did not display changes within the V3 loop itself. Thus, HIV strains lacking the 306N-glycan primarily develop resistance to V3-directed neutralization through acquisition of the specific oligosaccharide. This demonstrates that protein glycosylation can be a primary modifier of virus antigenicity of possible importance for the interaction of HIV with the host immune response.

* Author for correspondence. Fax +45 3647 4979. e-mail infejesh@inet.uni-c.dk

Received 12 July 1995; accepted 14 December 1995.


This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
R. J. P. Brown, A. W. Tarr, C. P. McClure, V. S. Juttla, N. Tagiuri, W. L. Irving, and J. K. Ball
Cross-genotype characterization of genetic diversity and molecular adaptation in hepatitis C virus envelope glycoprotein genes
J. Gen. Virol., February 1, 2007; 88(2): 458 - 469.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
R. J. P. Brown, V. S. Juttla, A. W. Tarr, R. Finnis, W. L. Irving, S. Hemsley, D. R. Flower, P. Borrow, and J. K. Ball
Evolutionary dynamics of hepatitis C virus envelope genes during chronic infection
J. Gen. Virol., July 1, 2005; 86(7): 1931 - 1942.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Balzarini, K. Van Laethem, S. Hatse, M. Froeyen, E. Van Damme, A. Bolmstedt, W. Peumans, E. De Clercq, and D. Schols
Marked Depletion of Glycosylation Sites in HIV-1 gp120 under Selection Pressure by the Mannose-Specific Plant Lectins of Hippeastrum Hybrid and Galanthus nivalis
Mol. Pharmacol., May 1, 2005; 67(5): 1556 - 1565.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Balzarini, K. Van Laethem, S. Hatse, K. Vermeire, E. De Clercq, W. Peumans, E. Van Damme, A.-M. Vandamme, A. Bohlmstedt, and D. Schols
Profile of Resistance of Human Immunodeficiency Virus to Mannose-Specific Plant Lectins
J. Virol., October 1, 2004; 78(19): 10617 - 10627.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. K. Gorny, K. Revesz, C. Williams, B. Volsky, M. K. Louder, C. A. Anyangwe, C. Krachmarov, S. C. Kayman, A. Pinter, A. Nadas, et al.
The V3 Loop Is Accessible on the Surface of Most Human Immunodeficiency Virus Type 1 Primary Isolates and Serves as a Neutralization Epitope
J. Virol., March 1, 2004; 78(5): 2394 - 2404.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. S. Cole, J. D. Steckbeck, J. L. Rowles, R. C. Desrosiers, and R. C. Montelaro
Removal of N-Linked Glycosylation Sites in the V1 Region of Simian Immunodeficiency Virus gp120 Results in Redirection of B-Cell Responses to V3
J. Virol., February 1, 2004; 78(3): 1525 - 1539.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Pantophlet, I. A. Wilson, and D. R. Burton
Hyperglycosylated Mutants of Human Immunodeficiency Virus (HIV) Type 1 Monomeric gp120 as Novel Antigens for HIV Vaccine Design
J. Virol., May 15, 2003; 77(10): 5889 - 5901.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
W. E. Johnson, J. M. Sauvron, and R. C. Desrosiers
Conserved, N-Linked Carbohydrates of Human Immunodeficiency Virus Type 1 gp41 Are Largely Dispensable for Viral Replication
J. Virol., December 1, 2001; 75(23): 11426 - 11436.
[Abstract] [Full Text]


Home page
J. Virol.Home page
D. C. Montefiori, J. T. Safrit, S. L. Lydy, A. P. Barry, M. Bilska, H. T. T. Vo, M. Klein, J. Tartaglia, H. L. Robinson, and B. Rovinski
Induction of Neutralizing Antibodies and Gag-Specific Cellular Immune Responses to an R5 Primary Isolate of Human Immunodeficiency Virus Type 1 in Rhesus Macaques
J. Virol., July 1, 2001; 75(13): 5879 - 5890.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. A. Ogert, M. K. Lee, W. Ross, A. Buckler-White, M. A. Martin, and M. W. Cho
N-Linked Glycosylation Sites Adjacent to and within the V1/V2 and the V3 Loops of Dualtropic Human Immunodeficiency Virus Type 1 Isolate DH12 gp120 Affect Coreceptor Usage and Cellular Tropism
J. Virol., July 1, 2001; 75(13): 5998 - 6006.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. M. Crawford, P. L. Earl, B. Moss, K. A. Reimann, M. S. Wyand, K. H. Manson, M. Bilska, J. T. Zhou, C. D. Pauza, P. W. H. I. Parren, et al.
Characterization of Primary Isolate-Like Variants of Simian-Human Immunodeficiency Virus
J. Virol., December 1, 1999; 73(12): 10199 - 10207.
[Abstract] [Full Text]


Home page
J. Virol.Home page
M. T. Esser, T. Mori, I. Mondor, Q. J. Sattentau, B. Dey, E. A. Berger, M. R. Boyd, and J. D. Lifson
Cyanovirin-N Binds to gp120 To Interfere with CD4-Dependent Human Immunodeficiency Virus Type 1 Virion Binding, Fusion, and Infectivity but Does Not Affect the CD4 Binding Site on gp120 or Soluble CD4-Induced Conformational Changes in gp120
J. Virol., May 1, 1999; 73(5): 4360 - 4371.
[Abstract] [Full Text]


Home page
J. Virol.Home page
S. Ohgimoto, T. Shioda, K. Mori, E. E. Nakayama, H. Hu, and Y. Nagai
Location-Specific, Unequal Contribution of the N Glycans in Simian Immunodeficiency Virus gp120 to Viral Infectivity and Removal of Multiple Glycans without Disturbing Infectivity
J. Virol., October 1, 1998; 72(10): 8365 - 8370.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1996 by the Society for General Microbiology.